Sentence and cancer type
Showing 261-279 of 279 items.
SentenceCancertype
Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor alpha mediates the induction of keratin 8 by the v-rasHa oncogene. None
Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. None
Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene. None
Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study. None
Expression of the erb B oncogene in the Morris hepatoma 7777. None
Retroviral capture of c-erbB proto-oncogene sequences: rapid evolution of distinct viral genomes carrying mutant v-erbB genes with different transforming capacities. None
The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. None
Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. None
Proto-oncogene of genomic DNA, related to the human epidermal growth factor receptor (EGFR) gene, from clinically normal domestic animals. None
The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. None
Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri. None
Ligand-independent dimerization of oncogenic v-erbB products involves covalent interactions. None
c-neu oncoprotein in developing rostral cerebral cortex: relationship to epidermal growth factor receptor. None
Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. None
A truncated RAR alpha co-operates with the v-erbB oncogene to transform early haematopoietic progenitors in vitro and in vivo. None
Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor. None
Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to an EGF-receptor-specific antibody-toxin. None
Oncogenic Ha-Ras-dependent mitogen-activated protein kinase activity requires signaling through the epidermal growth factor receptor. None
Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. None